Tabitha Bowker
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Respiratory Support and Mechanisms
Papers in
-
- COVID-19 Clinical Research Studies 4
- Surgery 1
- Kawasaki Disease and Coronary Complications 1
Tabitha Bowker
5 papers receiving 352 citations
Tabitha Bowker's Hit Papers
Peers
Comparison fields: 5 of 48
- Infectious Diseases 218
- Pulmonary and Respiratory Medicine 28
- Endocrinology, Diabetes and Metabolism 15
- Epidemiology 28
- Geriatrics and Gerontology 3
Countries citing papers authored by Tabitha Bowker
This map shows the geographic impact of Tabitha Bowker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tabitha Bowker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tabitha Bowker more than expected).
Fields of papers citing papers by Tabitha Bowker
This network shows the impact of papers produced by Tabitha Bowker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tabitha Bowker. The network helps show where Tabitha Bowker may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 2 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 3 | 2023 | 25 | |
| 4 | 2024 | 24 | |
| 5 | 2025 | 5 |
About Tabitha Bowker
Tabitha Bowker is a scholar working on Infectious Diseases, Surgery, Nuclear Energy and Engineering, Waste Management and Disposal and Organic Chemistry, having authored 5 papers that have together received 369 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (218 citations), Pulmonary and Respiratory Medicine (28 citations), Endocrinology, Diabetes and Metabolism (15 citations), Epidemiology (28 citations) and Geriatrics and Gerontology (3 citations). Their work appears in journals such as The Lancet, The Lancet Infectious Diseases, The Lancet Diabetes & Endocrinology and The Lancet Child & Adolescent Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.